Back to results
US 2016/0108397 A1Published application
Targeting micrornas for the treatment of fibrosis
AssigneeRegulus Therapeutics Inc.
InventorB. Nelson Chau
Life of this patent
Estimating the term…
Abstract
Provided herein are compositions and methods for the modulation of miR-214 for the treatment and/or prevention of fibrosis and fibroproliferative conditions.
Claims34
A method of treating, preventing, or delaying the onset of fibrosis comprising
- administering to a subject having fibrosis or at risk for developing fibrosis a compound comprising a modified oligonucleotide consisting of 8 to 12 linked nucleosides, and having a nucleobase sequence that is fully complementary to the nucleobase sequence of miR-214.
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
-29. (canceled)
(canceled)
(canceled)
(canceled)
(canceled)
-44. (canceled)
Dependencies are inferred from the claim text.